ChemoMetec
ChemoMetec A/S is a Danish public medtech company that designs automated fluorescence-based cell counting instruments and proprietary disposable cassettes for pharmaceutical, biotech, and academic customers in cell-and-gene-therapy, bioprocessing, and research applications.
- Company typePublic
- Founded1997
- HeadquartersAllerød, Denmark
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What ChemoMetec does
ChemoMetec A/S, founded in 1997 and headquartered in Allerød, Denmark, designs, manufactures, and sells automated cell counting and analysis instruments used by pharmaceutical, biotechnology, and academic customers to quantify cells in drug development, bioprocessing, and quality control. Its core technology is fluorescence-based image cytometry that uses proprietary, volume-calibrated disposable cassettes (Via1, Via2, Via3) to eliminate the subjectivity and pipetting error inherent in manual trypan-blue counting. The product portfolio spans the NucleoCounter family (NC-200, NC-202, NC-203, NC-250, NC-3000) for routine cell counting, the higher-throughput XcytoMatic platform (XM30, XM40) for cGMP bioprocessing, and the Ovizio iLine F PRO holographic microscope acquired in October 2024 for in-process monitoring. Supporting software includes XM Octopus for centralized fleet management, predictive modeling, and 21 CFR Part 11-compliant data handling, plus XM-View and NC-View for instrument analysis.
The company's primary customers are cell-and-gene-therapy manufacturers (CAR-T, CAR-NK, TILs, dendritic vaccines), biopharmaceutical and vaccine producers, bioprocess development labs, academic research institutions, and animal-reproduction operations. Revenue is generated through three streams: one-time instrument sales, recurring consumables (cassettes and reagents), and a service portfolio that includes GMP-Ready Service Plans, validation plans, IQ/OQ protocols, and training/certification services. The company sells primarily through a direct enterprise field-sales organization with quote-based pricing, supported by free product demonstrations, industry conferences, webinars, and content marketing. ChemoMetec is publicly listed on Nasdaq Copenhagen under ticker CHEMM and reports FY2025/26 revenue guidance of DKK 565-580M and EBITDA of DKK 320-335M, with Q3 2025/26 delivering DKK 142.3M in revenue (+15% YoY) and DKK 84.5M in EBITDA at a 59% margin.
ChemoMetec firmographics
Firmographics- Name
- ChemoMetec
- Legal name
- ChemoMetec A/S
- Website
- https://chemometec.com
- Company type
- Public
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- ChemoMetec A/S is a Danish public medtech company that designs automated fluorescence-based cell counting instruments and proprietary disposable cassettes for pharmaceutical, biotech, and academic customers in cell-and-gene-therapy, bioprocessing, and research applications.
- Ownership category
- akta.pro rank
ChemoMetec industry classification
Industry- Product category
- Laboratory Cell Counting Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industries
- Flow Cytometry & Cellular Analysis Diagnostics (HLAHAAAF), Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability) (HLAAABAK)
Keywords
Where ChemoMetec is headquartered
LocationHeadquarters
- HQ city
- Allerød
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
ChemoMetec business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Instrument Sales: Sale of automated cell counters and analyzers (NucleoCounter NC-200, NC-202, NC-203, NC-250, NC-3000, XcytoMatic 30, XcytoMatic 40, SP-100). Instruments are high-precision capital equipment sold directly to pharmaceutical, biotech, and research customers. Q3 2025/26 showed strong instrument sales growth with XcytoMatic products more than quadrupling to DKK 14.6 million.
- Consumables (Cassettes, Reagents, Slides): Recurring revenue from proprietary disposable cassettes (Via1, Via2, Via3), reagents, and slides required for instrument operation. Consumables declined 10% in Q3 2025/26 due to lower activity in existing approved therapies.
- Service Plans and Support: Annual service plans (GMP-Ready Service Plans, standard Service Plans) and validation plans that provide regular instrument qualification, compliance support, and priority technical assistance.
- Training and Certification: On-site operator training and certification programs for GMP manufacturing staff, conducted by ChemoMetec instructors with certification through theoretical and hands-on testing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Custom enterprise pricing based on instrument model, service plan tier, and volume |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
ChemoMetec product offering
Product offeringCore offering
ChemoMetec develops, manufactures, and sells automated cell counting and analysis instruments using fluorescence-based image cytometry combined with proprietary disposable cassette technology. The product portfolio includes the NucleoCounter and XcytoMatic instrument lines, the Ovizio iLine F PRO holographic microscope, proprietary Via-cassette consumables, and GMP-ready software platforms. Products serve pharmaceutical, biotech, and academic customers for cell counting in research, bioprocess monitoring, and GMP-compliant cell therapy manufacturing.
Product overview
ChemoMetec offers a comprehensive portfolio of automated cell counting and analysis instruments designed, manufactured, and tested in Denmark since 1997. The current product line centers on the XcytoMatic platform (XcytoMatic 40 and XcytoMatic 30) and NucleoCounter NC-203 for modern bioprocessing and cGMP manufacturing, complemented by software platforms (XM Octopus for centralized fleet management and XM-View/NC-View for analysis). The NucleoCounter legacy line (NC-200, NC-250, NC-3000) continues until April 2027 with service support through 2029. Specialized instruments include the SP-100 sperm counter. The acquired Ovizio iLine F PRO provides holographic microscopy for continuous bioprocess monitoring. All instruments use proprietary cassette technology (Via1, Via2, Via3) with pre-loaded fluorescent dyes for consistent, error-free cell counting. The company serves biotech, pharma, and academic segments worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- XcytoMatic: High-throughput automated cell counters for cGMP biomanufacturing, including XcytoMatic 40 and XcytoMatic 30 models
- NucleoCounter
- XM Octopus
- Via2-Cassette
- NC-View
- XM-View
Products and services
- XcytoMatic 40 (XM40) High-throughput cell density analyzer capable of processing approximately 100 samples per hour with up to 100 million cells/ml counting range. Combines brightfield and fluorescence microscopy with AI-powered XM-View software for automated debris tracking and cell diameter measurement. Designed for cGMP manufacturing of biologics, vaccines, and advanced therapies.
- XcytoMatic 30 (XM30) Flexible automated cell counter supporting both fully automated integrations and manual walk-up operation. Features API access for automated data retrieval and integrates with pipetting robots and bioreactors for hands-free cell counting workflows.
- NucleoCounter NC-203 High-precision cell counter combining cassette-based technology with brightfield imaging for robust differentiation between cells and debris. Uses XM-View software with API access for automated data retrieval and GMP/21 CFR Part 11 compliance.
- NucleoCounter NC-202 Third-generation automated cell counter featuring upgraded hardware and NC-View software. Delivers consistent results across instruments, users, and sites with DebrisIndex feature for measuring culture debris build-up. GMP/21 CFR Part 11 ready.
- NucleoCounter NC-200 High-precision automated cell counter using image cytometry for counting suspension cells, aggregated cells, CAR-T cells, stem cells, and cells on microcarriers. Will be discontinued and available only until April 2027.
- NucleoCounter NC-250 Automated cell analyzer with fluorescence imaging for characterizing cell properties. Offers optimized protocols for mammalian cells and unique assays for cells on microcarriers and sphere cultures. Available only until April 2027.
- NucleoCounter NC-3000 Advanced image cytometer using fluorescence imaging for high-speed analytical assays of mammalian, yeast, and insect cells. Features 5-minute cell cycle assay, apoptosis assays, and GFP assay with FlexiCyte customization option. Available only until April 2027.
- NucleoCounter SP-100 Automated sperm cell counter designed for animal reproduction applications. Determines total sperm concentration and viability from ejaculates or extended doses with virtually unlimited measurement range.
- Ovizio iLine F PRO Analyzer Online holographic microscope for continuous monitoring of critical quality attributes in bioprocesses. Works with wave bags, single-use and stirred tank bioreactors. Features machine learning algorithms for cell detection and parameter tracking, cGMP compliant.
- XM Octopus Centralized laboratory automation platform that integrates multiple instruments into unified workflows, enabling remote control, fleet management, quality control, and AI-powered predictive models. Supports REST API and WebSocket communication for real-time data acquisition and control.
- XM-View Software Shared software platform across XcytoMatic series and NC-203 instruments. Provides AI-powered analysis, API access for automated data retrieval, and 21 CFR Part 11 compliance for GMP environments.
- NC-View Software Software for NucleoCounter NC-202 providing data traceability with secure audit trail format. Compatible with 21 CFR Part 11 (EU Annex 11) and integrates into GMP setups with Secure Mode software package.
- Via3-Cassette Disposable cassette with pre-loaded fluorescent stains (AO and DAPI) for use with NucleoCounter NC-203. Creates closed cell-counting system eliminating pipetting errors and reagent exposure.
- Via2-Cassette Volume-calibrated disposable cassette with pre-loaded AO and DAPI stains for NucleoCounter NC-202. Eliminates pipetting errors and provides consistent cell counts across instruments and users.
- Via1-Cassette Disposable cassette with pre-loaded fluorescent stains for NucleoCounter NC-200 and NC-3000 instruments. Volume-calibrated to ensure high-precision counts and cell reproducibility.
- GMP-Ready Service Plans and Validation Plans Annual service plans (GMP-Ready Service Plans and standard Service Plans) and validation plans that provide regular instrument qualification, compliance support, and priority technical assistance for NucleoCounter and XcytoMatic instruments.
- Operator Training and Certification On-site operator training and certification programs for GMP manufacturing staff, conducted by ChemoMetec instructors with certification through theoretical and hands-on testing.
Quantifiable outcome
- Instrument-to-instrument variation under 5% (XcytoMatic 40)
- +4 more outcomes
Companies that use ChemoMetec
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
ChemoMetec technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability5 records
Feature7 records
ChemoMetec partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and preferred.
- Roche DiagnosticscoreCollaboration to develop and commercialize a connection kit linking Roche's Cedex Bio Analyzer with ChemoMetec's Xcytomatic 30 cell counter. Roche handles design and validation of the connection kit; both companies co-promote the combined solution while remaining sole sellers of their respective instruments. This partnership enhances integration capabilities for bioprocessing customers requiring connected analytics.
- TecanpreferredListed as a preferred partner on ChemoMetec's website, indicating an established working relationship for complementary product integration or distribution in laboratory automation workflows.
Scale indicators12 records
Recent moves7 records
Expansion highlights5 records
ChemoMetec competitors and assessment
Company assessmentBroad incumbents
- Agilent Technologies: Through its Cell Analysis portfolio (xCELLigence, NovoCyte flow cytometry, ACEA Biosciences), Agilent covers cell counting and cell-based assay use cases in pharma/biotech. Comparable in target customer, broader in platform scope.
- Becton Dickinson (BD Biosciences): Flow cytometry leader (BD Cell Viability kits, FACSChorus, FACSDiscover) used by biopharmaceutical and cell therapy manufacturers. Overlaps with ChemoMetec on cell-based QC but competes across a much broader product breadth.
- Thermo Fisher Scientific: Major instrument incumbent with the Countess automated cell counter and a broad flow cytometry and cell analysis portfolio serving bioprocessing, cell therapy, and research customers. Competes across the same workflow but as part of a much wider life sciences offering.
Direct peers
- Sartorius: Provides bioprocess analytics including cell density and viability sensors for upstream cell culture monitoring in the same biomanufacturing customers ChemoMetec serves with NC-203 and XcytoMatic. Increasingly competing in continuous/on-line cell monitoring alongside the Ovizio iLine F PRO.
- Beckman Coulter Life Sciences: Direct competitor in automated cell counting with the Vi-Cell series of cell viability analyzers targeting bioprocessing and research labs. Serves overlapping customer base with comparable cassette/sample-based fluorescence workflows.
- Bio-Rad Laboratories: Sells the TC20 automated cell counter, which directly competes with ChemoMetec's NucleoCounter line for routine cell counting in research and academic labs. Uses disposable counting slides similarly to ChemoMetec's cassette model.
Emerging players
- Sysmex Corporation: Japanese diagnostics leader expanding automated hematology and cell analysis capabilities into pharmaceutical/biotech QC. Less direct overlap than flow cytometry players but increasingly relevant for cell therapy process analytics.
- Sony Biotechnology: Developer of the CG-8000 cell sorter and MA900 multi-application cell sorter used in cell therapy manufacturing and cell biology research. Comparable in cell-therapy QC focus but with a different instrument category (sorters vs counters).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
ChemoMetec social profiles
Digital presenceChemoMetec compliance and trust
Trust signalCompliance7 records
ChemoMetec financial estimates
Financial estimateRevenue estimate
Valuation estimate
ChemoMetec leadership team
Management profileNumber of profiles
Profiles4 records
ChemoMetec subsidiaries and ownership
Company hierarchySubsidiaries1 record
ChemoMetec funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ChemoMetec M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ChemoMetec
What does ChemoMetec do?
ChemoMetec develops, manufactures, and sells automated cell counting and analysis instruments using fluorescence-based image cytometry combined with proprietary disposable cassette technology. The product portfolio includes the NucleoCounter and XcytoMatic instrument lines, the Ovizio iLine F PRO holographic microscope, proprietary Via-cassette consumables, and GMP-ready software platforms. Products serve pharmaceutical, biotech, and academic customers for cell counting in research, bioprocess monitoring, and GMP-compliant cell therapy manufacturing.
Is ChemoMetec a public or private company?
ChemoMetec is a public company. It is classified as public and is currently operating.
When was ChemoMetec founded?
ChemoMetec was founded in 1997. It employs 101 to 250 people.
Where is ChemoMetec based?
ChemoMetec is headquartered in Allerød, Denmark, in the Europe region.
How does ChemoMetec make money?
Four revenue lines are on record. Instrument Sales are the primary driver. The others are consumables (Cassettes, Reagents, Slides), service Plans and Support and training and Certification.
Who are ChemoMetec's main competitors?
Broad incumbents on record are Agilent Technologies, Becton Dickinson (BD Biosciences) and Thermo Fisher Scientific. Direct peers are Sartorius, Beckman Coulter Life Sciences and Bio-Rad Laboratories. Emerging players are Sysmex Corporation and Sony Biotechnology.
Does ChemoMetec have an API?
Yes. XM Octopus™ provides a REST API and WebSocket protocols for real-time instrument control, data exchange, and third-party system integration. The platform enables remote instrument operation, centralized data governance, and real-time operational oversight. Additionally, the Ovizio iLine F PRO Analyzer supports automation via RESTful web services (OPC ready). The NucleoCounter NC-203 provides API access through XM-View software for automated data retrieval and seamless integration into broader data-management architectures.
What industry is ChemoMetec in?
ChemoMetec's product category is Laboratory Cell Counting Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAHAAAF, Flow Cytometry & Cellular Analysis Diagnostics. Its NAICS code is 334516 and its SIC code is 3826.